Diva Laboratories (ROCO:4153) Dividend Payout Ratio: 0.00 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4153 Diva Laboratories Ltd ROCO:4153
74 GF Score
Price NT$31.40
GF Value NT$38.03
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Diva Laboratories Dividend Payout Ratio?

Diva Laboratories ROCO:4153 -1.88% 74 Dividend Payout Ratio is 0.00 as of Dec. 2025. GuruFocus rates ROCO:4153 with a GF Score™ of 74/100 and a GF Value™ of NT$38.03 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 54 Medical Diagnostics & Research companies, Diva Laboratories ranks worse than 79.63% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Diva Laboratories's Dividend Payout Ratio for the months ended in Dec. 2025 was 0.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Diva Laboratories Ltd is 1.34, which seems too high.

The historical rank and industry rank for Diva Laboratories's Dividend Payout Ratio or its related term are showing as below:

ROCO:4153' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.24   Med: 1.03   Max: 4.83
Current: 1.34

During the past 13 years, the highest Dividend Payout Ratio of Diva Laboratories was 4.83. The lowest was 0.24. And the median was 1.03.

ROCO:4153's Dividend Payout Ratio is ranked worse than
79.63% of 54 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.49 vs ROCO:4153: 1.34

As of today (2026-07-15), the Dividend Yield % of Diva Laboratories is 6.40%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Diva Laboratories was 9.35%. The lowest was 0.66%. And the median was 4.68%.

Diva Laboratories's Dividends per Share for the months ended in Dec. 2025 was NT$0.00.

During the past 12 months, Diva Laboratories's average Dividends Per Share Growth Rate was 60.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 75.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 17.80% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Diva Laboratories was 115.10% per year. The lowest was -40.70% per year. And the median was 72.15% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Diva Laboratories (ROCO:4153) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Diva Laboratories Dividend Payout Ratio Related Terms

Diva Laboratories Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Diva Laboratories's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diva Laboratories Dividend Payout Ratio Chart

Diva Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.82 0.24 0.69 0.71 1.25

Diva Laboratories Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 166.67 0.00 0.00

ROCO:4153 vs TMO, DHR, IDXX: Dividend Payout Ratio Comparison

For the Diagnostics & Research subindustry, Diva Laboratories's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diva Laboratories Dividend Payout Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diva Laboratories's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Diva Laboratories's Dividend Payout Ratio falls into.


ROCO:4153
74GF Score
Diva Laboratories Ltd ROCO:4153
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diva Laboratories Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Diva Laboratories's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=2/ 1.6
=1.25

Diva Laboratories's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2025 )/ EPS without NRI (Q: Dec. 2025 )
=0/ 0.636
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.00 mean?
Diva Laboratories (ROCO:4153) has a Dividend Payout Ratio of 0.00 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Diva Laboratories and its competitors. Over the past decade, Diva Laboratories' Dividend Payout Ratio has ranged from 0.24 to 4.83. According to the industry distribution chart, Diva Laboratories ranks #43 out of 54 companies in the Medical Diagnostics & Research industry, placing it in the top 79.6%.
Is Diva Laboratories' Dividend Payout Ratio too high?
Diva Laboratories' current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.24 to a high of 4.83. Based on the distribution chart, Diva Laboratories ranks #43 out of 54 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Diva Laboratories has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Diva Laboratories' Dividend Payout Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Diva Laboratories ranks #43 out of 54 companies for Dividend Payout Ratio. This places Diva Laboratories in the lower half of its industry. The industry median Dividend Payout Ratio is 0.49. Historically, Diva Laboratories' own Dividend Payout Ratio has ranged from 0.24 to 4.83 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Diagnostics & Research company?
The median Dividend Payout Ratio among Medical Diagnostics & Research companies is 0.49, based on 54 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Diva Laboratories and its competitors. For the Medical Diagnostics & Research industry, the median Dividend Payout Ratio is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diva Laboratories's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diva Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Diva Laboratories (ROCO:4153) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$38.03, compared to a current price of NT$31.40 — trading 17.4% below its estimated fair value. The current Dividend Payout Ratio is 0.00. Diva Laboratories' overall GF Score™ is 74/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Diva Laboratories (ROCO:4153), the current Dividend Payout Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diva Laboratories (ROCO:4153) Overvalued in 2026?

Based on GuruFocus' analysis, Diva Laboratories stock appears to be undervalued. The current stock price of NT$31.40 is trading 17.4% below its estimated GF Value™ of NT$38.03. GuruFocus considers Diva Laboratories to be Modestly Undervalued.

Key valuation signals for ROCO:4153:

  • Dividend Payout Ratio: 0.00
  • GF Value™: NT$38.03 vs. price of NT$31.40 (17.4% below fair value)
  • GF Score™: 74/100 with 2 warning signs

No single metric tells the full story. See the ROCO:4153 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diva Laboratories Business Description

Address Zhongshan Road, 9th Floor, No.351, Section 2, Zhonghe District, New Taipei City, TWN, 235602
Diva Laboratories Ltd is engaged in the sale, manufacturing and development of medical equipment and computer-related devices. Its products are divided into Medical display which includes radiology, endo/surgical, touch, and embedded display; and Industrial display which includes touch display monitors. It derives revenue from sale of Medical monitors, Medical parts, Industrial monitors, Industrial parts, and Parts. Geographically it operates and derives revenue from Taiwan.
74GF Score

Get the complete analysis for ROCO:4153

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.40
Price
NT$38.03
GF Value